Therapeutic efficiency of Tamoxifen/Orlistat nanocrystals against solid ehrlich carcinoma via targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 signaling pathways.
Thanaa A El-MasryMaysa M F El-NagarGhaleb Ali OriquatBadriyah S AlotaibiHebatallah M SaadEnas I El ZahabyHanaa A IbrahimPublished in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
The developed Tamoxifen/Orlistat nanocrystals combination could be considered a promising approach to augment antitumor effects.